Skip to main content
Caplight Logo









Aloft Biotechnologies

Aloft Biotechnologies

Private
Alachua, FloridaHealthcare & Life Scienceshttps://aloftbio.space/

Last Round

Grant

Jun 3, 2026

Total Funding Raised

$180,000

Company Overview

Aloft Biotechnologies is a biotechnology company that develops scalable bioprocessing equipment and bioreactor platforms for space-based cell culture and terrestrial cell therapy manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Space Technology, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

biomanufacturingspace biotechbioreactorcell therapy manufacturingmicrogravity researchorbital biomanufacturingcell culturebioprocessing hardwarefluid managementgas exchangespace manufacturingbiotech prototypingin-space productionlab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aloft Biotechnologies Comparables

Compare Aloft Biotechnologies with similar companies based on industry and business-model similarity.

Aloft Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ambrosia Space Manufacturing Corporation
80%
Space Tango
71%
Yuri
70%

Aloft Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 3, 2026
SeedMay 21, 2025

Key People

Founding team and executive leadership

Isaac Finger-Baker

Chief Technology Officer

Executive Team

Aloft Biotechnologies Investors

Notable investors and investment history

Aloft Biotechnologies investors
InvestorRounds
Space FloridaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2025

    $130K raised in Seed round.

Aloft Biotechnologies Filings

Explore SEC and related filing metadata, where available.

Aloft Biotechnologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Aloft Biotechnologies's valuation, stock price, and market status.

Is Aloft Biotechnologies a public or private company?

Aloft Biotechnologies is a private company.

What is the current stock price of Aloft Biotechnologies?

Aloft Biotechnologies is a private company with no public stock price. Caplight tracks Aloft Biotechnologies's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Aloft Biotechnologies worth (valuation)?

Valuation information for Aloft Biotechnologies is not publicly available.

Can I buy Aloft Biotechnologies stock?

Aloft Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Aloft Biotechnologies's last funding round?

Aloft Biotechnologies's most recent funding round was Grant on June 3, 2026.

Who are the main investors in Aloft Biotechnologies?

Key investors in Aloft Biotechnologies include Space Florida.

Will Aloft Biotechnologies IPO soon?

No public IPO plans have been announced for Aloft Biotechnologies.

How can I track Aloft Biotechnologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aloft Biotechnologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAlachua, Florida
Employee Range3
Year Founded2023
Last FundingJun 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?